WBA stock is trading at $11.98 on NASDAQ intraday on 27 Feb 2026, with volume at 452081061.00 shares, making Walgreens Boots Alliance one of today’s most active U.S. healthcare names. We see the heavy turnover against a 50-day average price of $11.66 and a 200-day average of $10.81, suggesting institutional or event-driven flows. Market cap is 10369421068.00 USD, and intraday momentum is lifting price by 0.06 (0.50%), so we focus on why traders moved in and what that means for short-term and 12-month outlooks.

Market snapshot: WBA stock volume and intraday action

WBA stock is a top intraday mover because volume is 452081061.00, roughly 26.69x its average volume of 16940296.00, creating sharp liquidity and price discovery. The stock opened at $11.98 and the session high and low are both $11.98, reflecting a concentrated trade block or auction imbalance. Year range sits between $8.08 and $13.25, so today’s activity sits closer to the upper quartile of the 52-week range.

Fundamentals and WBA stock valuation

Walgreens Boots Alliance (WBA) reports EPS of -7.29 and a trailing PE of -1.64, which reflects recent losses and one-off items. Price-to-sales is 0.07 and price-to-book is 1.44, indicating the market values WBA at low sales multiples but modest book coverage. Debt-to-equity is 4.04, and current ratio is 0.60, showing leverage and working capital pressure versus peers in the Healthcare sector. These raw numbers explain why WBA trades at depressed multiples despite steady revenues.

Meyka AI grade and WBA stock analysis

Meyka AI rates WBA with a score out of 100: Score 62, Grade B, Suggestion HOLD. This grade factors S&P 500 comparison, sector trends, financial growth, key metrics, forecasts, and analyst consensus. The company rating mix shows a C+ from other models and a split analyst consensus (Hold to Sell). We present the grade as a composite signal, not financial advice.

Technical outlook and WBA stock trading signals

Short-term technicals show extreme intraday momentum: RSI 100.00 and ADX 50.00, consistent with a strong trend but also short-term overbought conditions. ATR is 0.16, and Keltner channels center at 11.93 with upper at 12.26, framing the current price. On balance volume equals today’s reported volume, confirming buyer-initiated activity. Traders should watch whether volume sustains or reverses at intraday auction levels.

Price targets and WBA stock forecast

Meyka AI’s forecast model projects a 12-month price target of $14.50, implying an upside of 21.04% from $11.98. We also show scenarios: conservative $10.00 (downside -16.53%), base $13.50 (upside 12.69%), and bull $18.00 (upside 50.25%). These targets combine cash-flow multiples, sector comparables, and operating trends. Forecasts are model-based projections and not guarantees.

Risks, catalysts and WBA stock outlook

Key near-term catalysts include retail same-store sales, pharmacy margin trends, and the next earnings announcement on 2025-06-25. Risks include high leverage (debt-to-equity 4.04) and negative EPS. International operations and wholesaling exposure add geopolitical and reimbursement variability. Short interest updates and institutional flows can amplify intraday moves; see recent short-interest reporting at MarketBeat. Historical price context is available at Investing.com.

Final Thoughts

WBA stock traded at $11.98 intraday on 27 Feb 2026 with unusually high volume of 452081061.00, marking it among the most active NASDAQ healthcare names today. Fundamentals show low sales multiples (P/S 0.07) but heavy leverage (debt-to-equity 4.04) and negative EPS of -7.29, which keep valuation sensitive to earnings recovery. Meyka AI’s view blends these signals: our grade is B (62) with a HOLD suggestion, and Meyka AI’s forecast model projects a 12-month target of $14.50 (implied upside 21.04%). We emphasize scenario planning: conservative downside to $10.00 and a bull case to $18.00. Traders focusing on most-active flows should confirm volume sustainability and upcoming earnings data before positioning. All figures are model-driven or historic, not guarantees, and we recommend cross-checking with company releases and institutional filings. For continuous intraday tracking use our Meyka AI-powered market analysis tools and the WBA page at https://meyka.ai/stocks/WBA.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.